Yeah I have read it and it’s largely about the trial protocol rather than any news.
there are 3 main parts to the article:
1. Overview of Pathophysiology of heart failure
2. Overview of how MSC’s may work to improve patient with heart failure including phase 2 results
3. How the trial is structured and how that structure compares to previous trials in heart failure
nothing to write home about in any of it to be competetely honest but it’s good for MSB to get their name out there I guess.
Ann: Circulation Research Highlights MSB Heart Failure Therapy, page-34
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.025(1.68%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $13.99M | 9.339M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 64125 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 3044 | 4 |
View Market Depth
| Last trade - 14.16pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |